Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-24 @ 11:50 PM
NCT ID:
NCT02638051
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed PC with malignant ascites.
* Karnofsky Performance Status (KPS) score ≥60%.
* Normal function of bone marrow.
* Predicted survival time \>1 month.
* Written informed consent.
Exclusion Criteria:
* Surgery within 3 weeks or not full recovery of postoperative suture.
* Active bleeding or vascular occlusion in the mEHT treatment area.
* Emotional instability.
* Impossibility to place the patient into the mEHT machine.
* Metallic implants or replacements in the treatment area.
* Electronic implanted devices anywhere.
* Missing or damaged heat-sense nerves or other field-sensitive issues in the treatment area.
* Very low white blood cell count (\<1.5×10(9)/L), agranulocytosis (\<0.5×10(9)/L) or severe anemia.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02638051
Study Brief:
Protocol Section:
NCT02638051